Literature DB >> 19966930

Obsessive-Compulsive Disorder Symptoms in Huntington's Disease: A Case Report.

Juan Carlos Molano-Eslava1, Angela Iragorri-Cucalón, Gonzalo Ucrós-Rodríguez, Carolina Bonilla-Jácome, Santiago Tovar-Perdomo, David V Herin, Luis Orozco-Cabal.   

Abstract

INTRODUCTION: Few cases of obsessive-compulsive disorder (OCD) symptoms preceding the clinical onset of Huntington Disease (HD) or during later stages of the disease have been reported in the literature, but the nature of this association and its neurobiological mechanisms have not been well-investigated.
OBJECTIVES: To review the scientific literature regarding OCD symptoms in patients with HD and describe a case study from our clinic.
METHODS: Extensive literature searches were performed to identify reports of patients with concurrent HD and OCD symptoms.
RESULTS: Recent studies and the current case report suggest that OCD symptoms may predate or coincide with motor, affective or behavioral symptoms in patients with HD. The development of OCD and HD symptoms may involve structural and functional changes affecting the orbital and medial prefrontal cortex, ventromedial caudate nucleus, and pallidal sites.
CONCLUSIONS: Some patients with HD develop symptoms associated with OCD. Progressive and differential neuropathological changes in the ventromedial caudate nucleus and related neural circuits may underlie this association. No specific treatment strategy has been developed to treat these patients; however some medications attenuate associated symptoms. Further testing is needed to determine the neurobiological mechanisms of these disorders.

Entities:  

Year:  2008        PMID: 19966930      PMCID: PMC2788954          DOI: 10.1901/jaba.2008.37-644

Source DB:  PubMed          Journal:  Rev Colomb Psiquiatr        ISSN: 0034-7450


  63 in total

1.  Alterations in dopaminergic receptors in Huntington's disease.

Authors:  T D Reisine; J Z Fields; L Z Stern; P C Johnson; E D Bird; H I Yamamura
Journal:  Life Sci       Date:  1977-10-15       Impact factor: 5.037

2.  Huntington's disease: getting closer.

Authors:  J Timothy Greenamyre
Journal:  Am J Psychiatry       Date:  2007-09       Impact factor: 18.112

3.  11C-diprenorphine binding in Huntington's disease: a comparison of region of interest analysis with statistical parametric mapping.

Authors:  R A Weeks; V J Cunningham; P Piccini; S Waters; A E Harding; D J Brooks
Journal:  J Cereb Blood Flow Metab       Date:  1997-09       Impact factor: 6.200

4.  Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells.

Authors:  A Kazantsev; E Preisinger; A Dranovsky; D Goldgaber; D Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  HEAT repeats in the Huntington's disease protein.

Authors:  M A Andrade; P Bork
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

6.  Functional and motor response to low dose olanzapine in Huntington's disease: case report.

Authors:  Jerson Laks; Marlos Rocha; Claudia Capitão; Romeu Côrtes Domingues; Giovanna Ladeia; Maurício Lima; Eliasz Engelhardt
Journal:  Arq Neuropsiquiatr       Date:  2004-12-15       Impact factor: 1.420

7.  Cortical peptide changes in Huntington's disease may be independent of striatal degeneration.

Authors:  M F Mazurek; S Garside; M F Beal
Journal:  Ann Neurol       Date:  1997-04       Impact factor: 10.422

8.  Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease.

Authors:  G Sedvall; P Karlsson; A Lundin; M Anvret; T Suhara; C Halldin; L Farde
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

9.  Obsessive-compulsive disorder in Huntington's disease.

Authors:  J L Cummings; K Cunningham
Journal:  Biol Psychiatry       Date:  1992-02-01       Impact factor: 13.382

10.  PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline.

Authors:  A B Young; J B Penney; S Starosta-Rubinstein; D S Markel; S Berent; B Giordani; R Ehrenkaufer; D Jewett; R Hichwa
Journal:  Ann Neurol       Date:  1986-09       Impact factor: 10.422

View more
  4 in total

1.  An International Survey-based Algorithm for the Pharmacologic Treatment of Obsessive-Compulsive Behaviors in Huntington's Disease.

Authors:  Karen Anderson; David Craufurd; Mary C Edmondson; Nathan Goodman; Mark Groves; Erik van Duijn; Daniel P van Kammen; Lavonne Goodman
Journal:  PLoS Curr       Date:  2011-09-20

2.  Obsessive-Compulsive and Perseverative Behaviors in Huntington's Disease.

Authors:  Mayke Oosterloo; David Craufurd; Hanneke Nijsten; Erik van Duijn
Journal:  J Huntingtons Dis       Date:  2019

3.  Genetic and Environmental Contributors to Neurodegeneration: An Exploration of the Effects of Alcohol on Clinical Features of Huntington's Disease Using the Enroll-HD Global Platform.

Authors:  Alexander L Symonds; Antonella Macerollo; Kevin Foy; Sundus H Alusi; Rhys Davies
Journal:  Int J Environ Res Public Health       Date:  2021-05-12       Impact factor: 3.390

4.  The Spectrum of Psychiatric Pathology in a Patient with Genetically Verified Huntington's Disease.

Authors:  Samir Alkabie; Daljinder Singh; Amy Hernandez; Rhaisa Dumenigo
Journal:  Case Rep Psychiatry       Date:  2015-09-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.